Have a personal or library account? Click to login
The Etiology of Kidney Failure in Indonesia: A Multicenter Study in Tertiary-Care Centers in Jakarta Cover

The Etiology of Kidney Failure in Indonesia: A Multicenter Study in Tertiary-Care Centers in Jakarta

Open Access
|Jun 2023

References

  1. 1The Centers for Disease Control and Prevention (CDC). Global Health – Indonesia. Centers for Disease Control and Prevention; 2021. Accessed September 20, 2022. https://www.cdc.gov/globalhealth/countries/indonesia/pdf/indonesia-fs.pdf.
  2. 2Indonesian Society of Nephrology. 11th Annual Report of Indonesian Renal Registry 2018. Bandung: Indonesian Society of Nephrology; 2018.
  3. 3Indonesian Ministry of Health. Indonesian Health Profile 2021. Jakarta: Indonesian Ministry of Health; 2021.
  4. 4Lydia A, Rachmaningrum G, Shatri H, Nugroho P. Factors associated with late referral in end stage renal disease patents at Dr. RSUPN Cipto Mangunkusumo Hospital. J. Penyakit Dalam Indones. 2020; 7(2): 110116. DOI: 10.7454/jpdi.v7i2.433
  5. 5The National Institute of Health Research and Development, Indonesian Ministry of Health. Laporan Riset Kesehatan Dasar (Riskesdas) 2007. Jakarta: Indonesian Ministry of Health; 2007.
  6. 6The National Institute of Health Research and Development, Indonesian Ministry of Health. Laporan Riset Kesehatan Dasar (Riskesdas) 2013. Jakarta: Indonesian Ministry of Health; 2013.
  7. 7The National Institute of Health Research and Development, Indonesian Ministry of Health. Laporan Riset Kesehatan Dasar (Riskesdas) 2018. Jakarta: Indonesian Ministry of Health; 2018.
  8. 8Siswati T, Paramashanti BA, Rialihanto MP, Waris L. Epidemiological transition in Indonesia and its prevention: A narrative review. JOCAMR. 2022; 18(1): 5060. DOI: 10.9734/jocamr/2022/v18i130345
  9. 9Hustrini NM, Susalit E, Rotmans JI. Prevalence and risk factors for chronic kidney disease in Indonesia: An analysis of the National Basic Health Survey 2018. J. Glob. Health. 2022; 12: 04074. DOI: 10.7189/jogh.12.04071
  10. 10Salman M, Khan AH, Adnan AS, et al. Attributable causes of chronic kidney disease in adults: A five-year retrospective study in a tertiary-care hospital in the northeast of the Malaysian Peninsula. Sao Paulo Med J. 2015; 133(6): 502509. DOI: 10.1590/1516-3180.2015.005
  11. 11Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022; 102(5S): S1S127. DOI: 10.1016/j.kint.2022.06.008
  12. 12Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013; 3: 1150.
  13. 13Persson F, Rossing P. Diagnosis of diabetic kidney disease: state of the art and future perspective. Kidney Int Suppl (2011). 2018; 8(1): 27. DOI: 10.1016/j.kisu.2017.10.003
  14. 14Radhakrishnan J. Glomerular disease: Evaluation and differential diagnosis in adults. In: Glassock, RJ, Rovin, BH, Lam, AQ, (eds.), UpToDate, Post, TW (Ed). Waltham, MA: UpToDate; 2023. [cited: 2023 May 01]. Available from: https://www.uptodate.com/contents/glomerular-disease-evaluation-and-differential-diagnosis-in-adults?search=Glomerular%20disease:%20Evaluation%20and%20differential%20diagnosis%20in%20adults&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1
  15. 15Johansen KL, Chertow GM, Gilbertson DT, et al. US Renal Data System 2021 Annual Data Report: Epidemiology of kidney disease in the United States. Am J Kidney Dis. 2022; 79(4 suppl 1): SviiiSxi; S1-S575. DOI: 10.1053/j.ajkd.2022.02.001
  16. 16Huijben JA, Kramer A, Kerschbaum J, et al. Increasing numbers and improved overall survival of patients on kidney replacement therapy over the last decade in Europe: an ERA registry study. Nephrol Dial Transplant. 2022;114: gfac165. DOI: 10.1093/ndt/gfac165
  17. 17Zhao X, Niu Q, Gan L, et al. Baseline data report of the China Dialysis Outcomes and Practice Pattern Study (DOPPS). Sci Rep. 2021; 11: 873. DOI: 10.1038/s41598-020-79531-4
  18. 18Hemmelgarn BR, James MT, Manns BJ, et al. Rates of treated and untreated kidney failure in older vs younger adults. JAMA. 2012; 307(23): 25072515. DOI: 10.1001/jama.2012.6455
  19. 19Neild GH. Life expectancy with chronic kidney disease: an educational review. Pediatr Nephrol. 2017; 32: 243248. DOI: 10.1007/s00467-016-3383-8
  20. 20Mahmood U, Healy HG, Kark A, et al. Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service. BMC Nephrol. 2017; 18: 372. DOI: 10.1186/s12882-017-0781-5
  21. 21O’Hare AM, Choi AI, Bertenthal D, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007; 18(10): 27582765. DOI: 10.1681/ASN.2007040422
  22. 22Elliot MJ, Tam-Tham H, Hemmelgarn BR; Alberta Kidney Disease Network. Age and treatment of kidney failure. Curr Opin Nephrol Hypertens. 2013; 22(3): 344350. DOI: 10.1097/MNH.0b013e32835fe540
  23. 23Lai TS, Hsu CC, Lin MH, Wu VC, Chen YM. Trends in the incidence and prevalence of end-stage kidney disease requiring dialysis in Taiwan: 2010–2018. J Formos Med Assoc. 2022; 121(Suppl 1): S511. DOI: 10.1016/j.jfma.2021.12.013
  24. 24Bozorgmehri S, Aboud H, Chamarthi G, et al. Association of early initiation of dialysis with all-cause and cardiovascular mortality: A propensity score weighted analysis of the United States Renal Data System. Hemodial Int. 2021; 25(2): 188197. DOI: 10.1111/hdi.12912
  25. 25Stel VS, Dekker FW, Ansell D, et al. Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transplant. 2009; 24(10): 31753182. DOI: 10.1093/ndt/gfp264
  26. 26Liu Y, Wang L, Han X, et al. The profile of timing dialysis initiation in patients with end-stage renal disease in China: A cohort study. Kidney Blood Press Res. 2020; 45: 180193. DOI: 10.1159/000504671
  27. 27Hanafusa N, Fukagawa M. Global Dialysis Perspective: Japan. Kidney360. 2020; 1(5): 416419. DOI: 10.34067/KID.0000162020
  28. 28Escoli R, Luz I, Santos P, Vila Lobos A. Glomerular filtration rate and initiation of dialysis. Ther Apher Dial. 2017; 21(6): 606610. DOI: 10.1111/1744-9987.12582
  29. 29Umami V, Lydia A, Nainggolan G, Setiati S. Pengembangan model prediksi mortalitas 3 bulan pertama pada pasien penyakit ginjal kronik yang menjalani hemodialisis. J. Penyakit Dalam Indones. 2015; 2(3): 170182. DOI: 10.7454/jpdi.v2i3.82
  30. 30Prodjosudjadi W. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia. Ethn Dis. 2006; 16(2 Suppl 2): S2-1416.
  31. 31Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives. Nat Rev Endocrinol. 2011; 8(4): 228236. DOI: 10.1038/nrendo.2011.183
  32. 32Manne-Goehler J, Atun R, Stokes A, et al. Diabetes diagnosis and care in sub-Saharan Africa: pooled analysis of individual data from 12 countries. Lancet Diabetes Endocrinol. 2016; 4(11): 903912. DOI: 10.1016/S2213-8587(16)30181-4
  33. 33Hoogeveen EK. The Epidemiology of Diabetic Kidney Disease. Kidney Dial. 2022; 2: 433442. DOI: 10.3390/kidneydial2030038
  34. 34Okada T, Nagao T, Matsumoto H, Nagaoka Y, Wada T, Nakao T. Clinical significance of microscopic haematuria in diabetic nephropathy in type 2 diabetes patients with overt proteinuria. Nephrology (Carlton). 2013; 18(8): 563568. DOI: 10.1111/nep.12104
  35. 35Tesar V, Hruskova Z. Lupus Nephritis: A different disease in european patients? Kidney Dis (Basel). 2015; 1(2): 110118. DOI: 10.1159/000438844
  36. 36Choi HS, Han KD, Jung JH, et al. The risk of end-stage renal disease in systemic lupus erythematosus: A nationwide population-based study in Korea. Medicine (Baltimore). 2019; 98(28): e16420. DOI: 10.1097/MD.0000000000016420
  37. 37Lydia A, Saraswati MH, Dharmeizar D, Saraswati M, Setiati S. Diagnostic determinants of proliferative lupus nephritis based on clinical and laboratory parameters: A diagnostic study. Acta Med Indones. 2018; 50(2): 110118.
  38. 38Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021; 100(4S): S1S276. DOI: 10.1016/j.kint.2021.05.021
  39. 39Indonesian Ministry of Health. National Formulary 2021. Jakarta: Indonesian Ministry of Health; 2021.
  40. 40Alexander, RT, Hemmelgarn, BR, Wiebe, N, et al; Alberta Kidney Disease Network. Kidney stones and kidney function loss: a cohort study. BMJ. 2012; 345: e5287. DOI: 10.1136/bmj.e5287
  41. 41Dhondup T, Kittanamongkolchai W, Vaughan LE, et al. Risk of ESRD and mortality in kidney and bladder stone formers. Am J Kidney Dis. 2018; 72(6): 790797. DOI: 10.1053/j.ajkd.2018.06.012
  42. 42Liu Y, Chen Y, Liao B, et al. Epidemiology of urolithiasis in Asia. Asian J Urol. 2018; 5(4): 205214. DOI: 10.1016/j.ajur.2018.08.007
  43. 43Paidi G, Iroshani Jayarathna AI, Salibindla DR, et al. Chronic kidney disease of unknown origin: A mysterious epidemic. Cureus. 2021; 13(8): e17132. DOI: 10.7759/cureus.17132
  44. 44Fitria L, Prihartono NA, Ramdhan DH, Wahyono TYM, Kongtip P, Woskie S. Environmental and occupational risk factors associated with chronic kidney disease of unknown etiology in West Javanese rice farmers, Indonesia. Int J Environ Res Public Health. 2020; 17(12): 4521. DOI: 10.3390/ijerph17124521
DOI: https://doi.org/10.5334/aogh.4071 | Journal eISSN: 2214-9996
Language: English
Submitted on: Feb 3, 2023
Accepted on: May 16, 2023
Published on: Jun 1, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2023 Ni Made Hustrini, Endang Susalit, Aida Lydia, Maruhum Bonar H. Marbun, Muhammad Syafiq, Yassir, Johanes Sarwono, Elizabeth Yasmine Wardoyo, Jonny, Suhardjono, Rizki Y. Pradwipa, Anitasari Nugraheni, Merel van Diepen, Joris I. Rotmans, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.